Drug Profile
Recombinant human ErbB3 fragment vaccine - Zensun
Alternative Names: Recombinant human neu epitope peptide 12 - Zensun; rhErbB3-f - Zensun; Therapeutic Tumour Vaccine - ZensunLatest Information Update: 28 May 2019
Price :
$50
*
At a glance
- Originator Zensun (Shanghai) Sci & Tech
- Class Cancer vaccines
- Mechanism of Action ERBB 2 receptor antagonists; ERBB-3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 May 2019 No recent reports of development identified for phase-I development in Cancer in China (Parenteral, Injection)